ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRM Proteome Sciences Plc

2.65
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.65 2.30 3.00 - 0.00 13:55:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 5.03M -2.44M -0.0083 -3.19 7.82M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 2.65p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.30p to 5.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £7.82 million. Proteome Sciences has a price to earnings ratio (PE ratio) of -3.19.

Proteome Sciences Share Discussion Threads

Showing 157551 to 157571 of 158000 messages
Chat Pages: Latest  6308  6307  6306  6305  6304  6303  6302  6301  6300  6299  6298  6297  Older
DateSubjectAuthorDiscuss
17/5/2024
10:44
I think the suggestion by Pike of 'going to the Grand National' is quite possibly the must useful utterance by any PRM director ever, and one which I wish I'd heard in 2001 instead of 2024 ... the outcome of that alternative would surely have been better ...
bluemango
17/5/2024
10:40
blue, I've edited my post above after checking the webcast again.
jeffian
17/5/2024
10:34
To be fair to Randox, you simply can't rush these things. Imo 7 or 8 years is nothing. There's surely got to be much more pen-pushing, meetings and further meetings and risk assessments and further meetings before anything appears from Randox and possibly not in our lifetimes.

(Edited to correct the number of years of procrastination - thanks jeffian)

bluemango
17/5/2024
09:46
No he didn't (I watched it online; it's 25 min in). In response to a leading question submitted by a shareholder (you?!) "Will Randox release their stroke test this year?", Pike referred to it as "the perennial question which has appeared for the last 7/8 years". The response was 'we hope so', but we are not in the driving seat and Randox will not release anything until it is 'market ready' (whatever that means). He said he had no specific knowledge and Randox did not have to release any information, though he suggested you might find out more 'if you went to the Grand National'. (Randox are sponsors). He "hoped" it would appear in the second half of the year. I bet he does.

There was also a question about the latest markers for tau and the reported encouraging progress in this area. Pike said plainly that "none of the tau tests in the market infringe PRM's IP" though it was possible that some of their markers may become involved in combination with others at a later stage. So much for the "Toll Booth" eh?!

(Edited for correction following a review of the meeting)

jeffian
17/5/2024
08:30
wasjobber. What does he mean by 'this'?
dominiccummings
17/5/2024
07:15
At the AGM yesterday Ian Pike confirmed that Randox look to be releasing their stroke blood test this year!

Thanks Ian.

STRONG BUY

wasjobber
16/5/2024
21:50
re 92932 proteomespeak

It is still not a good long-term platform and significant growth looks required from here to reassure on even the gross cash position. I suggest it is in that context that current performance insight is required rather than about “customer contact” and “quotations provided”. Ahead of further balance sheet insight, an £11.2 million market cap continued avoid/sell.

shareprophets

elpirata
16/5/2024
18:13
Just watched the AGM,and it kind of explains everything and why the company is in the position it finds itself in.What an absolute bunch of amateurs.I don't think they know what's going on themselves,so where all the guff on here comes from I don't know.All them to pay plus the lab staff.Not a chance we will ever see a return here.
peverill
16/5/2024
17:24
Well, Christopher has aged a bit since I met him all those years ago.A better year ahead looks likely. Pity none of the gang want to buy some shares to back their confidence...
049balt
16/5/2024
10:46
There's a presentation on the Investormeet website at 12.00 if you're interested GRC.
jeffian
16/5/2024
09:59
So how was the agm? Any news on Stroke? Were they same as always or is there a spark of life in the old place. Anyone see behind the face masks?
glennrcharles
16/5/2024
09:08
The service business will not keep this afloat alone,it needs licensing agreements for the IP.Namely AD,but everyone is skirting around the patents as they please or they don't need them.Then they decide to out license to some obscure company that low and behold a PRM director is in hoc with,laughable.
peverill
16/5/2024
09:06
They're still very wedded to Proteome-speak, aren't they?

"Since the start of 2024, we have seen significant customer engagement and interest in proteomics services reflected by the considerable increase in customer contact and quotations provided"

"Sales" is a word which doesn't seem to exist in their dictionary.

jeffian
16/5/2024
09:01
Last years AGM statement

The Board is confident that the progress over the recent years has created an excellent platform for further development of the Group. Following the investment made over the last two years, a strong order book, new projects, high customer interest, our healthy cash position and recently announced expansion into the US, the Group has a strong base for 2023 and beyond. Proteome Sciences is well set to achieve a step-change in growth which gives the Board increased confidence that the business can continue to significantly grow revenue and EBITDA in the coming years."

amt
16/5/2024
08:59
Haha,never understood the need for multiple personalities,I know it exists,the Mrs has a few ,but on a free BB,naaah!!
peverill
16/5/2024
08:07
30 years ago, it was mostly thought that protein information was not required and genetics would be the solution to everything. In fact, it can be argued that even 5-10 years ago most thought the same. That attitude by most has only relatively recently changed and the proteome is now considered important.

STRONG BUY

wasjobber
16/5/2024
08:00
It is just possible that this time it is different. Let's see.
049balt
16/5/2024
06:27
Didn't he say the same for the last 30 years.This time next year Rodney.
peverill
15/5/2024
18:30
No. Leave it chums. That is a VERY FAIR yellow. I am suitably punished.
dominiccummings
15/5/2024
16:48
Not long now till the presentation,how exciting it's going to be.Half an hour of pure drivel about drivel.
peverill
15/5/2024
08:49
It is a straight red after VAR intervention.
monte1
Chat Pages: Latest  6308  6307  6306  6305  6304  6303  6302  6301  6300  6299  6298  6297  Older

Your Recent History

Delayed Upgrade Clock